Cargando…

Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data

INTRODUCTION: Although clinical guidelines are broadly available, the relationship between adherence and outcomes is not well studied. This study aimed to assess the association between adherence to National Comprehensive Cancer Network (NCCN) guidelines and clinical outcomes for adult patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Ani, Yang, Baiyu, Shah, Roma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932942/ https://www.ncbi.nlm.nih.gov/pubmed/33537872 http://dx.doi.org/10.1007/s12325-020-01617-2

Ejemplares similares

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment
por: Crowley, Fionnuala, et al.
Publicado: (2023)

The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO
por: Kim, Young Zoon, et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Population-Based Analysis of National Comprehensive Cancer Network (NCCN) Guideline Adherence for Patients with Anal Squamous Cell Carcinoma in California
por: Kumar, Priyanka, et al.
Publicado: (2023)

Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines
por: Wang, Xian-Ze, et al.
Publicado: (2020)

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)

Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers
por: Corbett, Virginia, et al.
Publicado: (2023)

An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC)
por: Sharp, John, et al.
Publicado: (2022)

Impact of the NCCN Biomarkers Compendium on Managed Care Pharmacy
por: Denno, Melissa S., et al.
Publicado: (2013)

Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)
por: Power, Nicholas E., et al.
Publicado: (2016)

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
por: Vaddepally, Raju K., et al.
Publicado: (2020)

Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines
por: Noy, Miguel Angel, et al.
Publicado: (2021)

Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022
por: Arboleda, Lady Paola Aristizabal, et al.
Publicado: (2023)

NCCN Imaging Appropriate Use Criteria Compendium: An Overview
por: Hagaman, Mistie G.
Publicado: (2017)

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
por: Raphael, Ari, et al.
Publicado: (2022)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
por: Moskovitz, Mor, et al.
Publicado: (2022)

NCCN Harmonized Guidelines for Sub-Saharan Africa: A Collaborative Methodology for Translating Resource-Adapted Guidelines Into Actionable In-Country Cancer Control Plans
por: Anderson, Benjamin O.
Publicado: (2020)

Outpatient sexually transmitted infection testing and treatment patterns in the United States: a real-world database study
por: Lillis, Rebecca, et al.
Publicado: (2023)

Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database
por: Huang, Ze-Ning, et al.
Publicado: (2018)

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
por: Kurzrock, R, et al.
Publicado: (2019)

Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
por: Teimouri, Arezou, et al.
Publicado: (2022)

From real-world electronic health record data to real-world results using artificial intelligence
por: Knevel, Rachel, et al.
Publicado: (2023)

Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines
por: van Riel, Sarah J., et al.
Publicado: (2017)

Can laparoscopic surgery be applied in gastric gastrointestinal stromal tumors located in unfavorable sites?: A study based on the NCCN guidelines
por: Huang, Chang-Ming, et al.
Publicado: (2017)

Leaders of ASCO, ASH, ASTRO, and NCCN Embrace Collaboration With Advanced Practitioners
por: Reckling, Susan
Publicado: (2014)

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2(nd)/3(rd)-Generation ALK Tyrosine Kinase Inhibitors (TKIs)
por: Raphael, Ari, et al.
Publicado: (2022)

Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
por: Nishida, Toshirou, et al.
Publicado: (2019)

Walk Your Talk: Real-World Adherence to Guidelines on the Use of MRI in Multiple Sclerosis
por: Tortora, Mario, et al.
Publicado: (2021)

Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact
por: Wilson, Brooke E., et al.
Publicado: (2021)

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients
por: Ma, Ming-Wei, et al.
Publicado: (2020)

Oncologists’ Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey
por: Shah-Manek, Bijal, et al.
Publicado: (2018)

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non‐Small Cell Lung Cancer in U.S. Community Medical Centers
por: Bernicker, Eric H., et al.
Publicado: (2021)

Value of Precision Medicine in Advanced Non‐Small Cell Lung Cancer: Real‐World Outcomes Associated with the Use of Companion Diagnostics
por: John, Ani, et al.
Publicado: (2020)

Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis
por: Davis, Jill, et al.
Publicado: (2021)

Identification of delirium from real-world electronic health record clinical notes
por: St. Sauver, Jennifer, et al.
Publicado: (2023)

Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus
por: Shen, Min, et al.
Publicado: (2023)

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
por: Mouritzen, Mette T., et al.
Publicado: (2021)

First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices
por: Liu, Stephen V., et al.
Publicado: (2022)

Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?
por: Bellesoeur, Audrey, et al.
Publicado: (2019)

Osimertinib in NSCLC: Real-World Data From New Zealand
por: So, Yeojeong Jane, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cf95t7r31ttoi3vlv88rjf1jgf